Crossref
Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”
Comprehensive Physiology · 2026-12 · 16 (6)
DOI: 10.1002/cph4.70312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comprehensive Physiology, online erschienen am 03.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”. Comprehensive Physiology, 16(6). https://doi.org/10.1002/cph4.70312
Vancouver
Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”. Comprehensive Physiology. 2026;16(6). doi:10.1002/cph4.70312
BibTeX
@article{euvimed2026,
title = {Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”},
journal = {Comprehensive Physiology},
year = {2026},
volume = {16},
number = {6},
doi = {10.1002/cph4.70312}
}
EUVIMED